Short interpregnancy interval after B-Lynch uterine compression suture: a case report

Nishikawa, Ai; Matsuzaki, Shinya; Mimura, Kazuya; Kanagawa, Takeshi; Kimura, Tadashi

doi:10.12891/ceog2085.2016

Cited by 9 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The firstline treatment for PPH includes pharmacological measures, intrauterine tamponade, uterine artery ligation, and uterine compression sutures. Uterine artery embolization (UAE) is performed for women with severe PPH that is refractory to treatment (5)(6)(7)(8)(9)(10)(11). When these conservative therapies fail, hysterectomy is performed.…”

Section: Introductionmentioning

confidence: 99%

Uterine artery embolization for postpartum hemorrhage with placenta accreta spectrum

Jeon

Kim

et al. 2023

Acta Radiol

View full text Add to dashboard Cite

Background The reported success rate of uterine artery embolization (UAE) for postpartum hemorrhage (PPH) differs by the cause of bleeding; in some reports, UAE shows less successful results in patients with placenta accreta spectrum (PAS). Purpose To evaluate the outcome of UAE for treating PPH associated with PAS. Material and Methods From September 2011 to September 2021, 227 patients (mean age = 34.67±4.06 years; age range = 19–47 years) underwent UAE for managing intractable PPH. Patients were divided into two groups: those with PAS (n = 46) and those without PAS (n = 181). Delivery details, embolization details, and procedure-related outcomes were compared between the two groups. P values <0.05 were considered statistically significant. Results The technical success rate was 96.9% (n = 222) and the clinical success rate was 93.8% (n = 215). There were no significant differences in outcome of UAE between the two patient groups. The technical success rate was 95.7% (n = 44) in patients with PAS and 98.3% (n = 178) in patients without PAS ( P = 0.267). The clinical success rate was 91.3% (n = 42) in patients with PAS and 95.6% (n = 173) in patients without PAS ( P = 0.269). There were 24 cases of immediate complications, including pelvic pain (n = 20), urticaria (n = 3), and puncture site hematoma (n = 1). No major complication was reported. Conclusion UAE is a safe and effective method to control intractable PPH for patients with or without PAS.

show abstract